Status:
COMPLETED
Dexmetomidine With Erector Spinae Plane Block in Cholecystectomy
Lead Sponsor:
Tanta University
Conditions:
Dexmedtomidine in Erector Spinae Block for Laparscopic Cholecystectomy
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
Sixty patients scheduled for elective laparoscopic cholecystectomy will be randomly assigned using sealed envelope into two equal groups (30 patients each). Group 1: will receive bilateral ESP block ...
Detailed Description
This prospective randomized study will be carried out in general surgery Department within 6 months from January 2022 to June 2022 on the 60 patients scheduled for elective laparoscopic cholecystectom...
Eligibility Criteria
Inclusion
- Patients undergoing elective laparoscopic cholecystectomy
- aged 18-65 years old
- ASA physical status I or II.
- Exclusion Criteria:
- patients who refuse to give written informed consent
- sever respiratory or cardiac disorder
- coagulopathy
- local infection at injection site
- spine or chest wall deformity
- patients with known allergy to the drugs used
Exclusion
Key Trial Info
Start Date :
January 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05369468
Start Date
January 22 2020
End Date
November 10 2022
Last Update
October 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University Hospitals
Tanta, Egypt, 31511